Evaluation of the Immunomodulatory Effects of a Probiotics and Natural Extract-Based Formulation in Bacterial-Induced Prostatitis
- PMID: 36836748
- PMCID: PMC9965078
- DOI: 10.3390/life13020389
Evaluation of the Immunomodulatory Effects of a Probiotics and Natural Extract-Based Formulation in Bacterial-Induced Prostatitis
Abstract
Among the many factors inducing prostate inflammation, bacterial contribution is potentially underrated according to the scientific community. Bacterial prostatitis is characterized by modifications of the prostatic microenvironment, mainly driven by the immune system. Macrophages play a major role in bacterial prostatitis, secreting a plethora of proinflammatory and chemoattractive cytokines and proteolytic enzymes able to degrade the ECM, so facilitating the invasion of other immune cells. Consequently, macrophages represent a link between bacterial infection and prostate inflammation, as well as being the main target of prostate anti-inflammatory drugs and dietary supplements. This study aims to investigate the effect of a formulation composed of active principles and a probiotic strain with a particular focus on the anti-inflammatory effect in an in vitro bacterial prostatitis model. The results obtained showed that the formulation reduces the inflammatory response of prostatic epithelium induced by bacterial infection. This effect is mediated by the modulation of activated macrophages. Analysis of the cytokines released highlights that the tested formulation is able to reduce the expression of key proinflammatory cytokines involved in the pathogenesis of prostate diseases, in particular prostate cancer, and represents a valuable tool to prevent bacterial prostatitis and ensure favorable prostate health.
Keywords: bacterial prostatitis; bromelain; cytokines; inflammation; probiotics; pumpkin extract.
Conflict of interest statement
The authors declare no conflict of interest.
Figures





Similar articles
-
Multidisciplinary approach to prostatitis.Arch Ital Urol Androl. 2019 Jan 18;90(4):227-248. doi: 10.4081/aiua.2018.4.227. Arch Ital Urol Androl. 2019. PMID: 30655633
-
Carica papaya leaf extract inhibits prostatitis-associated prostatic hyperplasia via the TRAF6/TAK1/MEK/NF-κB pathway.Biomed Pharmacother. 2021 Mar;135:111197. doi: 10.1016/j.biopha.2020.111197. Epub 2021 Feb 1. Biomed Pharmacother. 2021. PMID: 33433362
-
Antibiotic-loaded reactive oxygen species-responsive nanomedicine for effective management of chronic bacterial prostatitis.Acta Biomater. 2022 Apr 15;143:471-486. doi: 10.1016/j.actbio.2022.02.044. Epub 2022 Mar 5. Acta Biomater. 2022. PMID: 35259516
-
Chronic prostatitis/chronic pelvic pain syndrome and prostate cancer: study of immune cells and cytokines.Fundam Clin Pharmacol. 2020 Apr;34(2):160-172. doi: 10.1111/fcp.12517. Epub 2019 Nov 12. Fundam Clin Pharmacol. 2020. PMID: 31642541 Review.
-
[Bacterial prostatitis and prostatic fibrosis: modern view on the treatment and prophylaxis].Urologiia. 2016 Aug;(4):114-120. Urologiia. 2016. PMID: 28247738 Review. Russian.
References
-
- Mazzoli S. Conventional bacteriology in prostatitis patients: Microbiological bias, problems and epidemiology on 1686 microbial isolates. Arch. Ital. Urol. Androl. 2007;79:71–75. - PubMed
-
- Nickel J.C., Roehrborn C.G., O’Leary M.P., Bostwick D.G., Somerville M.C., Rittmaster R.S. The Relationship between Prostate Inflammation and Lower Urinary Tract Symptoms: Examination of Baseline Data from the REDUCE Trial. Eur. Urol. 2008;54:1379–1384. doi: 10.1016/j.eururo.2007.11.026. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources